SoftMedx Healthcare Limited (HKG:0648)
Hong Kong · Delayed Price · Currency is HKD 0.6100
-0.0300 (-4.69%)
Aug 13, 2026, 4:08 PM HKT
SoftMedx Healthcare Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.03 | 8.77 | 8.07 | 3.1 | 3.67 |
Short-Term Investments | 5.71 | 7.19 | 0.52 | 1.25 | 6.52 |
Trading Asset Securities | - | - | - | 0.02 | - |
Cash & Short-Term Investments | 17.74 | 15.97 | 8.59 | 4.36 | 10.19 |
Cash Growth | 11.11% | 85.94% | 96.77% | -57.17% | -19.07% |
Accounts Receivable | 15.08 | 16.74 | 7.11 | 1.04 | 1.67 |
Receivables | 15.08 | 16.74 | 7.11 | 1.04 | 1.67 |
Inventory | 5.44 | 4.78 | 2.83 | 1.97 | - |
Prepaid Expenses | 0.03 | 0.02 | 0.03 | 0.02 | 0.18 |
Other Current Assets | 9.77 | 12.3 | 16.55 | 11.21 | - |
Total Current Assets | 48.06 | 49.81 | 35.1 | 18.61 | 12.03 |
Property, Plant & Equipment | 0.52 | 0.94 | 0.45 | 1.32 | 1.64 |
Long-Term Investments | - | 3.92 | 20.53 | 4.71 | 5.44 |
Total Assets | 48.58 | 54.67 | 56.07 | 24.64 | 19.12 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.95 | 10.08 | - | - | - |
Accrued Expenses | 0.46 | 0.2 | 63.1 | 62.74 | 50.05 |
Current Portion of Long-Term Debt | 12.1 | 33.11 | 287.56 | 273.45 | 195.28 |
Current Portion of Leases | 0.38 | 0.36 | 0.21 | 0.89 | 1.08 |
Current Income Taxes Payable | 4.03 | 4.68 | 2.97 | 2.44 | 0.1 |
Current Unearned Revenue | 0.2 | 0.27 | 0.78 | 2.32 | - |
Other Current Liabilities | 0.89 | 2.95 | 22.08 | 24.57 | 20.86 |
Total Current Liabilities | 21 | 51.66 | 376.69 | 366.41 | 267.37 |
Long-Term Debt | - | - | 3.25 | 2.19 | 76.68 |
Long-Term Leases | 0.17 | 0.55 | - | - | - |
Total Liabilities | 21.17 | 52.21 | 379.93 | 368.6 | 344.05 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3,049 | 3,031 | 3,031 | 3,031 | 3,031 |
Retained Earnings | -3,021 | -3,028 | -3,355 | -3,367 | - |
Comprehensive Income & Other | - | - | - | - | -3,348 |
Total Common Equity | 27.41 | 2.46 | -323.86 | -336.37 | -317.35 |
Minority Interest | - | - | - | -7.58 | -7.58 |
Shareholders' Equity | 27.41 | 2.46 | -323.86 | -343.96 | -324.93 |
Total Liabilities & Equity | 48.58 | 54.67 | 56.07 | 24.64 | 19.12 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 12.65 | 34.03 | 291.01 | 276.52 | 273.03 |
Net Cash (Debt) | 5.09 | -18.06 | -282.43 | -272.16 | -262.84 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 0.18 | -1.11 | -17.32 | -16.69 | -16.12 |
Filing Date Shares Outstanding | 106.3 | 16.3 | 16.3 | 16.3 | 16.3 |
Total Common Shares Outstanding | 106.3 | 16.3 | 16.3 | 16.3 | 16.3 |
Working Capital | 27.06 | -1.85 | -341.59 | -347.8 | -255.34 |
Book Value Per Share | 0.26 | 0.15 | -19.87 | -20.63 | -19.47 |
Tangible Book Value | 27.41 | 2.46 | -323.86 | -336.37 | -317.35 |
Tangible Book Value Per Share | 0.26 | 0.15 | -19.87 | -20.63 | -19.47 |
Machinery | 3.65 | 4.53 | 4.53 | 4.53 | 4 |
Leasehold Improvements | 0.13 | 0.13 | 0.13 | 0.13 | 0.47 |